David G Drubin's lab at UC Berkeley focuses on understanding how cells take in materials and interact with their environment, particularly through a process called clathrin-mediated endocytosis (CME). They study this process in both yeast and human stem cells, using advanced imaging techniques to look at the proteins involved and how they function together. Their research aims to uncover the mechanisms behind how cells differentiate and respond under various conditions, which could have implications for understanding diseases and developing treatments.

Dr. Stephen C. Blacklow's lab at Harvard Medical School focuses on understanding the molecular mechanisms of cellular signaling, particularly through Notch signaling and tetraspanin proteins. They employ advanced technologies to visualize how signals are transmitted within cells, which is important for understanding diseases like cancer and immune disorders. The lab's research aims to pave the way for future therapeutic strategies by elucidating the roles of these signaling pathways in both normal physiology and disease states.

Dr. David S. Fay's lab at the University of Wyoming focuses on understanding how cells transport materials and how this affects their development and the surrounding structures they rely on. Using the tiny worm C. elegans as a model, the lab investigates how specific proteins regulate the movement of lipids and proteins within cells, which is crucial for building healthy tissues. The research aims to uncover the links between cellular transport, development, and various diseases, including cancer and neurological disorders.

Dr. Enrico Di Cera's lab at Saint Louis University focuses on understanding the structural biology of blood coagulation. They use advanced techniques like cryo-electron microscopy to study crucial proteins involved in hemostasis, such as prothrombin and factor V. By investigating how these proteins activate and interact, the lab aims to uncover new insights into blood coagulation processes that could have significant implications for therapies related to clotting disorders.

Dr. Ben E. Black's lab at the University of Pennsylvania focuses on understanding how chromosomes are inherited accurately during cell division. They study the centromeres, which are crucial for the proper segregation of chromosomes, to develop artificial chromosomes with potential medical applications. The lab combines structural biology and innovative genome technologies to tackle significant challenges in genome engineering and improve our understanding of genetics.

Dr. Feng Guo's lab focuses on discovering new cancer drugs that target specific RNA structures involved in cancer development. By using advanced techniques in crystallography, the lab aims to identify small molecules that can inhibit harmful RNA called microRNAs, which contribute to cancer. Their innovative approach could lead to breakthroughs in cancer treatment by designing therapies that are more effective and targeted.

Dr. Joan A. Steitz's lab at Yale University studies how certain viruses can manipulate their host cells using noncoding RNAs, which are special RNA molecules that don't make proteins but influence gene function. By investigating these noncoding RNAs associated with oncogenic herpesviruses such as Epstein-Barr virus and Kaposi's sarcoma-associated virus, the lab aims to uncover novel mechanisms of RNA behavior and its implications in cancer. Their research could lead to new therapeutic strategies to combat viral infections and related cancers.

Dr. Jeremy F. Reiter's lab at UCSF studies the role of centrioles—structures essential for various cellular functions—in mammalian development. Their research focuses on understanding how defects in centrioles can lead to congenital diseases, particularly affecting the heart, lungs, and inner ear. By examining how different parts of centrioles contribute to cellular functions, the lab aims to uncover critical insights into developmental processes and disease mechanisms.

Dr. Bin Chen's lab at UC Santa Cruz focuses on understanding how neural stem cells in the brain develop into various cell types needed for proper brain function. The research aims to uncover the mechanisms behind how these stem cells switch from producing neurons to producing supporting glial cells during brain development. This work is crucial for understanding developmental disorders and may contribute to better treatments for brain-related diseases.

Dr. Yong Cheng's lab studies how specific long noncoding RNAs (lncRNAs), particularly FENDRR, help our immune system fight against tuberculosis, a severe bacterial infection. By examining how FENDRR is activated during infections and its role in immune response, the lab aims to uncover new treatment strategies for this widespread disease. The research not only focuses on understanding the biology behind inflammation and immune defense but also explores innovative therapies based on these findings.

Dr. Kwangjin Cho's lab at Wright State University focuses on understanding how specific lipids at the Golgi complex influence the composition and organization of the plasma membrane in human cells. By examining the role of phosphatidylinositol 4-phosphate and its impact on membrane protein localization, particularly the KRAS oncogene, the lab aims to uncover new insights into cellular signaling and potential vulnerabilities in cancer pathways. This research is critical for linking cellular metabolism to lipid regulation and offers implications for understanding and treating KRAS-driven cancers.

The research lab led by Scott G Holmes at Wesleyan University focuses on understanding how specific proteins interact to regulate key processes in cells, particularly those related to gene expression and chromosome stability. By studying histones H1 and H2A.Z, the lab investigates how the balance between these proteins affects how genes are turned on or off and how chromosomes are properly segregated during cell division. This research is important for uncovering the basis of various diseases linked to chromatin dysfunction.

Dr. Konstantinos Chronis's lab focuses on how certain factors can transform cells found in blood vessels into hematopoietic stem cells (HSCs), which are vital for producing blood cells. By understanding this reprogramming process, the lab aims to develop new methods for generating HSCs that could be used in medical treatments. Their research explores the genetic changes that happen during this transformation and how to make the process more efficient and effective for clinical applications.

Dr. Gino Cingolani's lab at the University of Alabama at Birmingham focuses on understanding how specific signaling proteins called STAT1 and STAT3 function in the body, especially in relation to innate immunity and in disease states. The lab also investigates how viruses deliver their genetic material into cells, exploring both bacterial viruses and herpesviruses. Research in this lab combines cutting-edge techniques to visualize and analyze these complex biological processes, potentially leading to new therapies for infectious diseases and immune disorders.

Peter Michael Clark's lab at UCLA focuses on improving how we understand cancer through advanced imaging techniques. They specifically study how different cancer cells absorb a radioactive glucose analog used in PET scans, aiming to identify unique subpopulations of cells that may respond differently to treatments. By developing innovative technology to measure this absorption at the single-cell level, the lab hopes to enhance the accuracy of cancer diagnoses and treatment evaluations.

Dr. Yu Chen's lab at the University of South Florida focuses on the bacteria Clostridioides difficile, which is a major cause of hospital infections. The lab studies how certain proteins in the bacteria help it resist antibiotics and contribute to its ability to produce resilient spores. By understanding these mechanisms, the lab aims to develop new treatments to combat recurring infections caused by this pathogen.

Dr. John M Coffin's lab at Tufts University focuses on studying human endogenous retroviruses (HERVs) and their potential to inhibit HIV replication. The lab aims to understand how certain HERVs can block viral assembly and explore their evolutionary history. Overall, the research seeks innovative strategies for preventing HIV infections through the activation of these natural viral inhibitors.

Professor Jeffery Coller's lab at Johns Hopkins University studies the role of codon optimality in determining the stability of messenger RNA (mRNA). By investigating how the rates at which ribosomes decode mRNA influence its degradation, the lab aims to uncover critical principles of gene regulation. Their research has implications for understanding cancer and viral infections, as these processes can disrupt normal cellular functions and exploit the mechanisms of gene expression.

Dr. Rui Zhang's lab at Washington University focuses on studying the structure and function of a vital organelle, the conoid, in the Toxoplasma gondii parasite. By examining the unique complexities of this structure, the lab aims to unlock insights that could contribute to developing more effective treatments for diseases caused by apicomplexan parasites. This research is crucial as it addresses significant gaps in our understanding of these pathogens, which are responsible for severe human health issues.

The lab led by Dr. Jeanette Gowen Cook at the University of North Carolina focuses on understanding the mechanisms that control cell division and how certain cancer cells can enter a dormant state called quiescence. This research is critical, as quiescent cancer cells often resist treatment, leading to cancer relapse. Using innovative biosensors, the lab aims to study the different states of cell quiescence and their impact on tumor behaviors. Ultimately, the team's work will contribute to improved cancer therapies and provide insights into how cells maintain their genetic integrity during division.